Nomura Holdings’s Halozyme HALO Stock Holding History

Nomura Holdings’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-99,000	Closed	-$5.18M	–	1727
2024 Q2	$5.18M	Buy	99,000 +27,200	+38%	+$1.19M	0.01%	651
2024 Q1	$2.92M	Buy	71,800 +29,800	+71%	+$1.12M	0.01%	795
2023 Q4	$1.55M	Buy	+42,000	New	+$1.58M	﹤0.01%	1049
2023 Q1	–	Sell	-82,500	Closed	-$4.69M	–	1565
2022 Q4	$4.69M	Buy	+82,500	New	+$4.22M	0.02%	513
2020 Q4	–	Sell	-40,500	Closed	-$1.06M	–	1570
2020 Q3	$1.06M	Buy	+40,500	New	+$1.13M	﹤0.01%	807

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's HALO Position: Q1 2026 in Review

Nomura Holdings sold out of Halozyme (HALO) in Q1 2026, closing a stake of 15,666 shares — an estimated $1.05M sold.

Nomura Holdings first reported a position in HALO in Q2 2013 and held it in 4 quarters. The position peaked at $1.05M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Nomura Holdings reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 15,666 Halozyme shares in Q1 2026, an estimated $1.05M.
Nomura Holdings first reported a position in Halozyme in Q2 2013 and held it in 4 quarters.
Nomura Holdings's Halozyme position peaked at $1.05M in Q4 2025.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.